Geode Capital Management
MITO

Geode Capital Management’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Geode Capital Management’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48,791
Closed -$15K – 5038
2022
Q3 		$15K Hold
48,791
– – ﹤0.01% 4950
2022
Q2 		$12K Hold
48,791
– – ﹤0.01% 4977
2022
Q1 		$34K Buy
48,791
+25,474
+109% +$17.2K ﹤0.01% 4882
2021
Q4 		$19K Sell
23,317
-1,185
-5% -$1.24K ﹤0.01% 4947
2021
Q3 		$33K Buy
+24,502
New +$33.2K ﹤0.01% 4815

Geode Capital Management's MITO Position: Q4 2022 in Review

Geode Capital Management sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 48,791 shares — an estimated $15K sold.

Geode Capital Management first reported a position in MITO in Q3 2021 and held it in 5 quarters. The position peaked at $34K in Q1 2022. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

  • Geode Capital Management reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
  • Geode Capital Management sold 48,791 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $15K.
  • Geode Capital Management first reported a position in Stealth BioTherapeutics Corp. ADS in Q3 2021 and held it in 5 quarters.
  • Geode Capital Management's Stealth BioTherapeutics Corp. ADS position peaked at $34K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.